ATPC Agape ATP Corporation: Price-to-Projected Revenue Ratio

Agape ATP Corporation (ATPC) is optimizing the development of metabolic formulas by outsourcing industrial production to external contractors. The forward price-to-sales ratio visualizes market expectations, where 1.20 expresses the current value of the metric. Rapid sales growth is driven by strong retail distribution. Supply chain stability is guaranteed through the diversification of transport routes and the maintenance of warehouse reserves.

Agape ATP Corp - ATPC Market Cap to Expected Sales Ratio (period 02/21/2024 - 11/15/2026)

Summary analytical data breakdowns for Agape ATP (ATPC)

- market price and analyst price targets:

Price Chart Agape ATP|ATPC - Average Forecast Price

- company stock capitalization data:

Market Value Agape ATP Corporation|ATPC - Total Company Value

- book value of equity indicators:

Book Value per Share Agape ATP|ATPC - Book Valuation of Business|Market Value to Book Value Ratio agapeatpgroup.com|ATPC - Company Total Asset Base

- business debt structure and liquidity details:

- financial results and valuation multiples details:

ATPC - Profit After Tax|Projected Future Earnings Agape ATP Corporation|ATPC - Market Cap to Earnings|Projected Price to Earnings Agape ATP Corporation|ATPC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Agape ATP|ATPC - Operating profit EBITDA|Net earnings per share for the last 12 months Agape ATP|ATPC - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months agapeatpgroup.com|ATPC - Earnings per share trend in current year|Expected earnings per share growth for next year Agape ATP Corporation

- sales volume and revenue indicators:

ATPC - Company Sales Revenue|Projected Sales Volume Agape ATP Corporation|ATPC - Market Cap to Revenue|Price-to-Projected Revenue Ratio Agape ATP Corporation|ATPC - Trailing Twelve Months Revenue Growth

Fundamental company analysis:agapeatpgroup.com ATPC

Forward P/S relates current market capitalization to expected sales volume, measuring the premium the market is willing to pay per unit of future revenue. For Agape ATP Corporation (ATPC), which is expanding through organic growth in Asia without M&A transactions, the forward P/S metric on GURU.Markets allows for an assessment of how this conservative expansion strategy aligns with market capitalization expectations.

Main competitors

Price-to-Projected Revenue Ratio ascendispharma.com ASND|Madrigal Corp (MDGL) - Market Cap to Future Revenue Ratio|CORT - Price-to-Projected Revenue Ratio|RYTM: Price-to-Projected Revenue Ratio|AKRO: Forward P/S Multiple|MTSR - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio MoonLake Corp|Crinetics Corp (CRNX) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio newamsterdampharma.com (NAMS)|Forward Price-to-Revenue Multiple soleno.life SLNO|Forward P/S Multiple FOLD (amicusrx.com)|Market Cap to Expected Sales Ratio 89bio (ETNB)|Agios - Forward P/S Multiple|Structure Corp - Price to Expected Revenue Ratio|mimedx.com (MDXG) - Price-to-Projected Revenue Ratio|Future Price to Revenue RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Forward P/S Multiple|Price-to-Projected Revenue Ratio MBX|Price-to-Projected Revenue Ratio Altimmune Pharma (ALT)|Price-to-Projected Revenue Ratio AARD (Aardvark Therapeutics Corp)|Forward P/S Multiple SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Market Cap to Future Revenue Ratio|BMEA: Forward Price-to-Revenue Multiple|Forward Price to Sales QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Forward Price-to-Revenue Multiple|vTv Therapeutics, Inc. - Forward Price to Sales|PLUR (pluri-biotech.com) - Forward P/S Multiple|SYBX: Forward Price to Sales|Forward P/S Multiple LPCN|Market Cap to Expected Sales Ratio Matinas BioPharma Holdings, Inc.|Price-to-Projected Revenue Ratio Spruce Biosciences Inc. SPRB|GLTO - Forward Price-to-Revenue Multiple|CTCX - Price-to-Projected Revenue Ratio|LUMO - Forward P/S Multiple|ONVO: Forward P/S Multiple|RDUS (Radius Recycling) - Price-to-Projected Revenue Ratio